Strasbourg, France, February 23, 2026 – We are thrilled to announce the launch of the 2026 Novalix-SCT Award for Drug Discovery Chemistry.
Created in 2022, this award aims to acknowledge excellence in drug discovery chemistry. This annual award is organized by the French Medicinal Chemistry Society SCT to support the international community of medicinal chemists.
The Novalix-SCT Award for Drug Discovery Chemistry will be attributed for outstanding results contributing to a scientific discovery and /or substantial therapeutic innovation and obtained by scientists without restrictions regarding nationality.
History and scope
- Specific emphasis will be given to the notion of drug discovery chemistry where combined disciplines, among for example molecular modeling, in silico approaches, chemistry, chemical-biology, biology or ADMET can contribute to the achievement of the team’s objectives.Specific emphasis will be given to the notion of drug discovery chemistry where combined disciplines, among for example molecular modeling, in silico approaches, chemistry, chemical-biology, biology or ADMET can contribute to the achievement of the team’s objectives.
- The Novalix-SCT Award for Drug Discovery chemistry (4,000 €) is given during the International Conference on Medicinal Chemistry (RICT*), an annual SCT meeting, by the SCT president.
Eligibility
- The applicant should be based in Europe and has to accomplish her/his duty as SCT member by paying the membership on the SCT website to be eligible.
- The “Novalix–SCT Award for Drug discovery chemistry” jury members select the laureate among the candidates.
- By accepting the award, the laureate team representative agrees to present a plenary lecture at the next RICT meeting or a SCT (co)-organized event in case RICT meeting cannot take place.
Nomination process
- Candidacies should be emailed to the SCT secretary, secretariat.general@sct-asso.fr as well as to the SCT president, president@sct-asso.fr .
- The candidates or candidate team representative should provide a short pdf document (font: Arial 11, space between lines: 1.15) describing their project with an emphasis on the main discoveries made in drug discovery, including the state of art, the context and the exceptional added value of the integrative approach in medicinal chemistry, the potential impact on the downstream phases, the perspectives.
- This has to be accompanied with the bibliographic references.
- In addition, a short CV of the team members should be added.
- The total length of this document (Contribution+Refs+CV) should not exceed 6 printed pages.
To discover the full details on the Novalix-SCT Award, click here: